Marcin Sumila
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Beck M, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti D, Reuter C, Gomez S, Khanfir K, Aebersold D, Ghadjar P, Schär C, Hayoz S, Papachristofilou A, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen D, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller A, Putora P, Pra A. Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial. Int J Radiat Oncol Biol Phys 2022; 113:80-91.
03.01.2022Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
03.01.2022Int J Radiat Oncol Biol Phys 2022; 113:80-91
Beck Marcus, Li Qiyu, Sumila Marcin, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Bosetti Davide G, Reuter Christiane, Gomez Silvia, Khanfir Kaouthar, Aebersold Daniel M, Ghadjar Pirus, Schär Corinne, Hayoz Stefanie, Papachristofilou Alexandros, Sassowsky Manfred, Schär Sämi, Mathier Etienne, Halter Matthias, Zwahlen Daniel R, Hölscher Tobias, Arnold Winfried, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Pra Alan Dal
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
Ghadjar P, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti D, Kaouthar K, Gomez S, Wust P, Thalmann G, Aebersold D, Sumila M, Schär C, Hayoz S, Bernhard J, Zwahlen D, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A, Plasswilm L, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. Eur Urol 2021; 80:306-315.
14.06.2021Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
14.06.2021Eur Urol 2021; 80:306-315
Ghadjar Pirus, Zaugg Kathrin, Guckenberger Matthias, Ost Piet, Reuter Christiane, Bosetti Davide G, Kaouthar Khanfir, Gomez Silvia, Wust Peter, Thalmann George N, Aebersold Daniel M, Sumila Marcin, Schär Corinne, Hayoz Stefanie, Bernhard Jürg, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Polat Bülent, Hildebrandt Guido, Müller Arndt-Christian, Plasswilm Ludwig, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
Ghadjar P, Kranzbühler H, Najafi Y, Ost P, Azinwi N, Reuter C, Bodis S, Kaouthar K, Budach V, Aebersold D, Thalmann G, Sumila M, Biaggi-Rudolf C, Stalder L, Hayoz S, Genitsch V, Zwahlen D, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A, Putora P, Papachristofilou A, Swiss Group for Clinical Cancer Research (SAKK). Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
19.01.2017Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer
19.01.2017BJU Int 2017; 120:E45-E51
Ghadjar Pirus, Kranzbühler Helmut, Najafi Yousef, Ost Piet, Azinwi Ngwa C, Reuter Christiane, Bodis Stephan, Kaouthar Khanfir, Budach Volker, Aebersold Daniel M, Thalmann George N, Sumila Marcin, Biaggi-Rudolf Christine, Stalder Lukas, Hayoz Stefanie, Genitsch Vera, Zwahlen Daniel R, Hölscher Tobias, Gut Philipp, Guckenberger Matthias, Hildebrandt Guido, Müller Arndt-Christian, Putora Paul Martin, Papachristofilou Alexandros, Swiss Group for Clinical Cancer Research (SAKK)
Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
Sassowsky M, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold D, Plasswilm L, Azinwi N, Zwahlen D, Gut P, Hölscher T, Hildebrandt G, Müller A, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Ghadjar P. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 2013; 87:534-41.
22.08.2013Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10
22.08.2013Int J Radiat Oncol Biol Phys 2013; 87:534-41
Sassowsky Manfred, Takacs Istvan, Reuter Christiane, Sumila Marcin, Manser Peter, Ost Piet, Böhmer Dirk, Pilop Christiane, Aebersold Daniel M, Plasswilm Ludwig, Azinwi Ngwa C, Zwahlen Daniel R, Gut Philipp, Hölscher Tobias, Hildebrandt Guido, Müller Arndt-Christian, Najafi Yousef, Kohler Götz, Kranzbühler Helmut, Guckenberger Matthias, Ghadjar Pirus